CRISPR technology is a core competency for Merck, a leading science and technology company that received its first U.S. patent in February 2019 for its proxy-CRISPR technology making CRISPR more efficient, flexible, and specific. The ....
CRISPR screening for coronavirus is in the works. CRISPR screening helps identify genes that cause diseases such as sickle-cell anemia, cancer, and lung cancer metastasis. The technology enables thousands of genes to be modified, helping ....
Passage Bio Files for IPO to Advance Gene Therapy Passage Bio is one of the gene therapy companies headquartered in Philadelphia that develops treatment for rare monogenic CNS diseases. They are planning to raise $125 million ....
CRISPR screening is a useful experimental approach used to facilitate the discovery of genes or genetic sequencing. According to a study done by researchers in the University of Toronto, long-tail mutations or less frequent mutations ....
ERS Genomics is a biotechnology company held by co-founder Dr. Emmanuelle Charpentier and was established to provide broad access to the foundational CRISPR-Cas9 intellectual property. It recently announced that the European Patent Office (EPO) has ....
Gene editing therapy has made another milestone when it successfully improved the memory and cognitive functions of mice under the study of scientists at Dongguk University in Seoul, South Korea. This brings mankind a step ....
Before gene therapy, people have been unsuccessfully battling macular degeneration or age-related macular degeneration (AMD or ARMD), a medical condition that may result in blurred or no vision in the center of the visual field. ....
CRISPR has gained a lot of attention in recent years, from curing diseases to yielding gene edited crops to modifying the human embryo. Aside from these, scientists are now exploring CRISPR for applications other than ....
Gene editing is designed to cleave DNA or RNA at desired locations within a genome. Its goal is to eradicate diseases as well as select a child’s traits. After much controversy and debate, the RNA-guided ....
In the new era where everything is fast-moving, the cancer immunotherapy field has combined DNA-editing CRISPR and T cell therapy to win the fight against tumors. Pioneering the studies were two females and one male, who ....
